Why is Oxygenta Pharma falling/rising?

As of 10-Nov, Oxygenta Pharmaceutical Ltd is experiencing a decline in its stock price, currently at Rs 62.40, which reflects a decrease of Rs 2.07 or 3.21%. The stock has been underperforming, having lost 6.64% over the last two days and is currently trading below its recent moving averages, specifically lower than the 5-day, 50-day, 100-day, and 200-day moving averages. Additionally, the stock has underperformed its sector by 4.26% today. In terms of returns, over the past week, the stock has decreased by 3.81%, while it has shown a significant decline of 28.66% year-to-date and 29.76% over the past year, despite a strong performance over the last three and five years.
Broader Market Context: In comparison to the benchmark Sensex, which has only decreased by 0.53% over the past week, Oxygenta's short-term performance is notably weaker. The Sensex has shown a positive return of 1.25% over the past month, while Oxygenta's return for the same period is a gain of 6.32%. This indicates that while the stock has had some positive momentum in the longer term, its recent performance has been adversely affected by broader market conditions and investor sentiment, contributing to its current decline.